PRTK
Paratek Pharmaceuticals Inc
Price:  
2.23 
USD
Volume:  
4,755,429.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTK WACC - Weighted Average Cost of Capital

The WACC of Paratek Pharmaceuticals Inc (PRTK) is 8.4%.

The Cost of Equity of Paratek Pharmaceuticals Inc (PRTK) is 11.75%.
The Cost of Debt of Paratek Pharmaceuticals Inc (PRTK) is 6.70%.

Range Selected
Cost of equity 8.90% - 14.60% 11.75%
Tax rate 0.20% - 0.30% 0.25%
Cost of debt 6.40% - 7.00% 6.70%
WACC 7.2% - 9.5% 8.4%
WACC

PRTK WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.03 1.69
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.90% 14.60%
Tax rate 0.20% 0.30%
Debt/Equity ratio 2.01 2.01
Cost of debt 6.40% 7.00%
After-tax WACC 7.2% 9.5%
Selected WACC 8.4%